Prolonged half-life of voriconazole in a CYP2C19 homozygous poor metabolizer receiving vincristine chemotherapy: avoiding a serious adverse drug interactionBrad Moriyama, Thomas J. Walsh, Janice M. Leung et al.|Mycoses|2011Cited by 19